And there's a possibility none of us thought about -- that they'd put out ANOTHER press release as the "corporate update" and that the conference call is an explanation of that.

So, guys, I guess we'll get a lot more data about the trials, but most likely no real bombshell.

Data is very, very welcome to this long and strong investor.